Analysis and optimization of the cationic lipid component of a lipid/peptide vector formulation for enhanced transfection in vitro and in vivo.
We have previously described a lipopolyplex formulation comprising a mixture of a cationic peptide with an integrin-targeting motif (K16GACRRETAWACG) and Lipofectin, a liposome consisting of DOTMA and DOPE in a 1:1 ratio. The high transfection efficiency of the mixture involved a synergistic interaction between the lipid/peptide components. The aim of this study was to substitute the lipid component of the lipopolyplex to optimize transfection further and to seek information on the structure-activity relationship of the lipids in the lipopolyplex. Symmetrical cationic lipids with diether linkages that varied in alkyl chain length were formulated into liposomes and then incorporated into a lipopolyplex by mixing with an integrin-targeting peptide and plasmid DNA. Luciferase transfections were performed of airway epithelial cells and fibroblasts in vitro and murine lung airways in vivo. The biophysical properties of lipid structures and liposome formulations and their potential effects on bilayer membrane fluidity were determined by differential scanning calorimetry and calcein-release assays. Shortening the alkyl tail from C18 to C16 or C14 enhanced lipopolyplex and lipoplex transfection in vitro but with differing effects. The addition of DOPE enhanced transfection when formulated into liposomes with saturated lipids but was more variable in its effects with unsaturated lipids. A substantial improvement in transfection efficacy was seen in murine lung transfection with unsaturated lipids with 16 carbon alkyl tails. The optimal liposome components of lipopolyplex and lipoplex vary and represent a likely compromise between their differing structural and functional requirements for complex formation and endosomal membrane destabilization.
Writer
Michele
M
Wolfson Centre for Gene Therapy of Childhood Disease, UCL Institute of Child Health, London, UK.
Hurley
Christopher A
CA
Sarkar
Supti
S
Copeman
Danielle M
DM
Wong
John B
JB
Odlyha
Marianne
M
Jayne Lawrence
M
M
Tabor
Alethea B
AB
McAnulty
Robin J
RJ
Ayazi Shamlou
Parviz
P
Hailes
Helen C
HC
Hart
Stephen L
SL
D000818:Animals; D002151:Calorimetry; D002412:Cations / Q000032:analysis / Q000737:chemistry; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004247:DNA / Q000235:genetics; D005452:Fluoresceins; D005822:Genetic Vectors / Q000235:genetics; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008055:Lipids / Q000032:analysis* / Q000737:chemistry* / Q000633:toxicity; D008081:Liposomes; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D015394:Molecular Structure; D010455:Peptides / Q000008:administration & dosage* / Q000737:chemistry*; D014162:Transfection / Q000295:instrumentation* / Q000379:methods*
D002412:Cations; D005452:Fluoresceins; D008055:Lipids; D008081:Liposomes; D010455:Peptides; D004247:DNA; C007740:fluorexon